Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

Related Posts

Fish consumption and gastric cancer within the Stomach cancer Pooling (StoP) Project

Franchi C, Ardoino I, Mandelli S, Patel L, Pelucchi C, Bonzi R, Camargo MC, Rabkin CS, Liao LM, Sinha R, Johnson KC, Hu J, Zhang[...]

The risk of type 2 diabetes among older Asian, Native Hawaiian and Pacific Islander colorectal cancer survivors:a population-based study using SEER-Medicare database

Liu K, Chang CE, Lloyd S, Tao R, Nguyen T, Zhang ZF, Hashibe M. The risk of type 2 diabetes among older Asian, Native Hawaiian[...]

Prognostic factors of survival in patients with lung cancer after low-dose computed tomography screening: a multivariate analysis of a lung cancer screening cohort in China

Li J, Xu HL, Li WX, Ma XY, Liu XH, Zhang ZF. Prognostic factors of survival in patients with lung cancer after low-dose computed tomography[...]